4-(1-Methylethyl)-2-Thiazolecarboxylicacid

4-(1-Methylethyl)-2-Thiazolecarboxylicacid


    • Product Name 4-(1-Methylethyl)-2-Thiazolecarboxylicacid
    • Alias 4-Isopropylthiazole-2-carboxylic acid
    • Einecs EINECS 415-090-6
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    245801

    Chemical Formula C7H9NO2S
    Molar Mass 171.217 g/mol
    Appearance Solid (usually)
    Physical State At Room Temp Solid
    Solubility In Water Poor (estimated, due to hydrophobic groups)

    As an accredited 4-(1-Methylethyl)-2-Thiazolecarboxylicacid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 500g of 4-(1 - Methylethyl)-2 - Thiazolecarboxylic acid in sealed, labeled chemical - grade containers.
    Shipping 4-(1 - Methylethyl)-2-Thiazolecarboxylic acid is shipped in containers designed to prevent leakage. Chemical - resistant packaging ensures safe transport, following strict regulations for handling and shipping of such substances.
    Storage Store 4-(1 - Methylethyl)-2 - Thiazolecarboxylic acid in a cool, dry place away from heat sources and direct sunlight. Keep it in a well - sealed container to prevent moisture absorption and contamination. Avoid storing it near reactive substances. If possible, store it in a dedicated chemical storage area following safety regulations for organic acids.
    Application of 4-(1-Methylethyl)-2-Thiazolecarboxylicacid

    Reductive amination sequences followed by amide coupling with 4-(1-methylethyl)-2-thiazolecarboxylic acid (IPTCA) represent a convergent strategy for assembling GPR40/FFA1 agonists that have progressed into Phase II clinical assessment for Type 2 diabetes. The free carboxylic acid is the primary pharmacophore anchoring point; its steric environment—the isopropyl group occupying the thiazole 4-position—attenuates PPARγ transactivation while preserving picomolar agonist potency at the GPR40 receptor. Process-scale manufacture of IPTCA-derived clinical candidates is governed by ICH Q7 Section 5.1.2 for starting material validation, with residual palladium limits set below 10 μg/g per FDA 21 CFR 211.160(b) in-process controls. In a representative convergent batch record, IPTCA is charged at 1.05-1.15 eq. relative to the amine fragment; an equimolar pre-activation with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC·HCl) and 1-hydroxybenzotriazole (HOBt) in anhydrous N,N-dimethylformamide at -5 to 0 °C suppresses the competing N-acylurea rearrangement and limits epimerization of the acid-labile prosthetic group on the eastern fragment. The coupling mass is quenched into 2 M hydrochloric acid at 0-5 °C, extracted with 2-methyltetrahydrofuran, and concentrated under reduced pressure with a jacket setpoint not exceeding 30 °C. Final recrystallization from isopropanol/water (72:28 v/v) yields the GPR40 agonist free acid with chemical purity exceeding 99.7 area% by HPLC (Inertsil ODS-3, 5 μm, 250 × 4.6 mm; mobile phase: 0.1% trifluoroacetic acid in acetonitrile/water gradient). The finished dosage form is an immediate-release tablet manufactured via roller compaction to circumvent moisture-induced dihydrate formation; tensile strength is held at 1.8-2.4 MPa per USP ⟨1062⟩. A comparative matrix of coupling reagents and their impact on epimerized byproduct formation at pilot scale (50 L reactor) is presented below.

    Coupling ReagentIPTCA:Amine Molar RatioCrude Purity (HPLC area%)Epimerized Byproduct (%)Throughput Limitation
    EDC·HCl / HOBt1.10:1.0096.30.7Exothermic onset at −8 °C; requires jacket ramp rate ≤ 0.5 K/min
    HATU / DIPEA1.05:1.0098.10.3Cost-prohibitive above 3 kg IPTCA charge
    T3P® / pyridine1.15:1.0094.81.1High aqueous solubility of byproduct complicates work-up

    What Limits the Coupling Yield in IPTCA-Derived FabH Inhibitor Libraries?

    β-Ketoacyl-acyl carrier protein synthase III (FabH) is a conserved bacterial target for methicillin-resistant Staphylococcus aureus (MRSA) therapeutics, and IPTCA has been employed as an acid fragment in arrayed solution-phase libraries of 2-aminothiazole amides. The steric demand of the isopropyl group slows acyl transfer at the 2-amino position; this kinetic bottleneck is mitigated by conducting the amidation in N-methyl-2-pyrrolidone at a controlled water activity of less than 0.2 aw with PyBOP (1.3 eq.) and N,N-diisopropylethylamine (3.0 eq.) relative to IPTCA. Bioassay-guided fractionation post-synthesis adheres to ICH M7 for DNA-reactive impurity alert structures; a purge factor calculation demonstrates that any unreacted IPTCA (predicted purge factor > 104) falls below the threshold of toxicological concern of 1.5 μg/day. The synthesis workflow is executed on a Tecan Freedom EVO liquid handler equipped with a 96-well filtration block, where IPTCA is dispensed as a 0.25 M stock in dimethyl sulfoxide. Crude products are captured on Strata-X polymeric reverse-phase cartridges and eluted with acetonitrile containing 0.05% formic acid. Minimum inhibitory concentration (MIC) values against MRSA USA400 strain are determined in cation-adjusted Mueller-Hinton broth following CLSI M07-A11; hit compounds with MIC ≤ 2 μg/mL are transitioned into time-kill kinetics. The terminal output is a lyophilized screening hit forwarded to a pharmacology unit; no solid-state characterization is performed at this stage.

    Industrial-scale preparation of succinate dehydrogenase inhibitor (SDHI) fungicide active ingredients entails converting IPTCA to its corresponding acid chloride under strictly anhydrous conditions. In a 2,500 L glass-lined reactor, IPTCA (1.0 kmol) is suspended in toluene containing 0.02 eq. pyridine catalyst; thionyl chloride (1.25 eq.) is metered at a rate that keeps the internal temperature between 48 and 52 °C. Process safety calorimetry (Mettler Toledo RC1, phi-factor 1.08) recorded a specific heat release of −210 kJ/kg and a maximum pressure rise rate of 1.2 bar/min under adiabatic conditions; the relief system is sized per DIERS methodology for a 2-phase vapor-liquid runaway scenario. The generated acid chloride is immediately coupled with a substituted aniline bearing a difluoromethyl moiety in the same solvent train without isolation; post-reaction, the organic layer is washed with 5% aqueous sodium bicarbonate and the amide product crystallizes upon cooling to −10 °C (crystal size d50 controlled at 8-12 μm via wet milling). The resulting technical-grade active ingredient is formulated as a 500 g/L aqueous suspension concentrate (SC) by bead milling with an EO/PO block copolymer dispersant and a xanthan gum rheology modifier, yielding a particle size below 2 μm (d90) measured by laser diffraction on a Malvern Mastersizer 3000. Finished product specifications align with the compliance matrix summarized below.

    Standard / RegulationRelevant SectionRequirement Applied to IPTCA-Derived SDHI
    FAO/WHO Specification 605/TCTechnical Material (Thifluzamide-type profile)Assay ≥ 97.0%; moisture ≤ 0.5%; acetone insolubles ≤ 0.3%
    EPA 40 CFR 158.500Product Chemistry DataComplete 5-batch analysis; accelerated storage stability at 54 °C for 14 days
    EU Regulation 1107/2009Annex III, Section 1ADI set at 0.01 mg/kg bw/day; MRL monitoring in cereals
    CIPAC MT 46.3Wet Sieve ResidueRetention on 75 μm sieve ≤ 0.1%

    Copper(I) Iodide Complexes of IPTCA-Derived Triazolylamine Ligands in Alkyne-Azide Click Chemistry

    IPTCA can be converted to a 2-(4-isopropylthiazol-2-yl)-1,2,3-triazole bidentate ligand via CuAAC reaction with propargylamine, providing a nitrogen-rich coordination sphere that stabilizes Cu(I) against oxidation in aqueous media. The catalyst system, prepared freshly by stirring the ligand (0.5 mol% relative to alkyne) with copper(I) iodide in acetonitrile at 25 °C for 30 min, accelerates the cycloaddition of biomolecule-bearing azides to strained alkynes without requiring a sacrificial reductant. The ligand-to-copper stoichiometry is maintained at 1.05:1.00; excess ligand shifts turnover frequency (TOF) downward through competitive binding to the vacant Cu(I) coordination site required for alkyne π-activation. Laboratory-scale preparation for bioconjugation is conducted under ISO 13485:2016 quality management when the adduct is destined for diagnostic kit assembly. The final product is a filtered solution of the active catalyst that is used directly in the conjugation step; no isolated material is stored. In a standard immunoglobulin G modification, 3 azide groups per antibody were introduced, and the IPTCA-ligated copper catalyst achieved quantitative conversion within 45 min as assessed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

    When IPTCA-Replaced Cysteine Fragments Are Introduced into Peptide Backbone Mimics for HCV NS3/4A Protease

    Thiazole-containing peptide isosteres reduce susceptibility to proteolytic cleavage while maintaining the hydrogen-bonding network critical for inhibition of the hepatitis C virus NS3/4A serine protease. Fmoc-IPTCA-OH, prepared by ester hydrolysis of the corresponding ethyl ester under lithium hydroxide in tetrahydrofuran/water (3:1 v/v), is deployed as a non-natural amino acid surrogate on Rink amide AM resin (loading 0.38-0.42 mmol/g). The steric profile of the 4-isopropyl substituent necessitates a triple-coupling protocol: 3 eq. Fmoc-IPTCA-OH is activated with HATU (2.9 eq.) and 2,4,6-trimethylpyridine (6 eq.) in dimethylformamide; each coupling cycle is held for 15 min at 70 °C on a Liberty Blue microwave peptide synthesizer with instrument-calculated power typically below 35 W. Following global deprotection with trifluoroacetic acid/triisopropylsilane/water (95:2.5:2.5 v/v/v), the crude peptide is precipitated in chilled diethyl ether and dried under nitrogen. Purification by preparative reversed-phase HPLC (C18, 10 μm, 5 × 25 cm column) using a gradient of acetonitrile in 0.1% aqueous formic acid yields the IPTCA-containing macrocycle at > 96% purity. Pharmacopeial compliance is benchmarked against USP ⟨1503⟩ and ICH Q6B; counterion content (trifluoroacetate) is controlled below 0.8% w/w as measured by ion chromatography. The final dosage form is a sterile lyophilized cake reconstituted prior to intravenous administration, with residual moisture determined by Karl Fischer coulometry at ≤ 1.5%.

    In non-halogen flame retardant epoxy formulations for copper-clad laminate production, IPTCA has been evaluated as a latent accelerator for dicyandiamide-cure systems at loadings of 0.5-1.5 phr. The lone pair on the thiazole nitrogen reversibly complexes the dicyandiamide nitrile group, shifting the cure exotherm peak to 168-172 °C (measured by differential scanning calorimetry at 10 K/min) and extending the prepreg gel time at 140 °C beyond 420 s. Compliance with IEC 61249-2-21 defines halogen-free requirements; the finished 4-layer laminate is processed via vacuum lamination at 175 °C under 3.5 MPa consolidation pressure for 90 min and subsequently subjected to solder float testing at 288 °C for 30 s per IPC-TM-650 Method 2.4.13.

    Free Quote

    Competitive 4-(1-Methylethyl)-2-Thiazolecarboxylicacid prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction
    Product supplied under catalog number THZ-4iPr-2CA-25G is a white to off-white crystalline solid with molecular formula C₇H₉NO₂S and a formula weight of 171.22 g·mol⁻¹. The compound, 4-(1-methylethyl)-2-thiazolecarboxylic acid, carries a secondary isopropyl substituent at the thiazole C-4 position and a carboxylic acid function at the C-2 position, rendering it an ambident building block for agrochemical and early-stage pharmaceutical discovery. Headspace gas chromatography–mass spectrometry of a freshly opened container typically reveals residual solvents below ICH Q3C Option 2 limits; the dominant polymorph, as verified by powder X-ray diffraction (Bruker D8 Advance, Cu Kα, 0.02° step), remains stable under ambient humidity below 40% RH. At relative humidity exceeding 65%, surface hydration initiates a small melt-recrystallization cycle that elevates the water content measured by Karl Fischer coulometry beyond 0.3% within 48 h.

    What Chromatographic Fingerprint Ensures Batch Equivalence Across Multiple Kilogram Campaigns?

    Routine lot release relies on reversed-phase high-performance liquid chromatography with a column of dimensions 150 × 4.6 mm packed with sub-3 µm fully porous C18 particles (e.g., Waters Acquity BEH C18) operated at 35 °C. Mobile phase A consists of 0.1% trifluoroacetic acid in water, mobile phase B of acetonitrile, and the gradient runs from 5% B to 95% B over 12 min at a flow rate of 1.0 mL·min⁻¹. Detection at 254 nm (bandwidth 4 nm, reference 360 nm) is calibrated against a multi-point external standard prepared from a reference material whose purity was established by quantitative 1H NMR using an internal certified standard of dimethyl terephthalate (traceable to NIST SRM 2135). Under these conditions the main peak elutes at a retention time of 6.8 ± 0.1 min. The acceptance criterion for area-percent purity is ≥ 98.5%, with individual unspecified impurities capped at 0.3%. The method has been validated according to ICH Q2(R1) for specificity, linearity (range 0.05–2.0 mg·mL⁻¹, r² > 0.999), and intermediate precision (inter-day RSD ≤ 0.6%). When the acid is subsequently transformed into its methyl ester for GC analysis on a mid-polar column (Restek Rxi-624Sil MS, 30 m × 0.25 mm, 1.4 µm film), the retention index matches the published value for the 4-isopropyl regioisomer, confirming positional integrity.

    Steric Bulk and Electronic Modulation Contrasted with the 4-Methyl and 5-Isopropyl Congeners

    Property4-(1-Methylethyl)-2-TCA4-Methyl-2-TCA5-Isopropyl-2-TCA2-Thiazolecarboxylic acid
    Melting range (DSC onset, ASTM E794, 10 K·min⁻¹)122–124 °C140–142 °C98–101 °C80–82 °C
    pKa (capillary electrophoresis, 25 °C, I = 0.15 M NaCl)3.31 ± 0.033.22 ± 0.033.10 ± 0.042.85 ± 0.02
    Calculated log D7.4 (ACD/Labs Percepta)−0.72−1.45−0.65−1.90
    Relative amidation rate with benzylamine (CDI, THF, 0 °C)0.781.000.911.32
    Typical residual Pd after Suzuki coupling on 5-bromo precursor≤ 15 ppm≤ 20 ppmN/AN/A
    Placement of the isopropyl group at the 4-position, adjacent to the ring nitrogen, introduces a steric shield that retards nucleophilic attack at the carbonyl while simultaneously exerting a hyperconjugative electron-donating effect, raising the pKa by 0.09 units relative to the 4-methyl homolog. In practice, when the series is subjected to identical carbodiimide-mediated amidation conditions (EDC·HCl/DMAP, CH₂Cl₂, 20 °C), the 4-isopropyl acid requires a 20–30% longer reaction time to reach >95% conversion, as monitored by inline ReactIR with a SiComp probe tracking the carbonyl stretch shift from 1714 cm⁻¹ to 1682 cm⁻¹. Conversely, the 5-isopropyl isomer, where the alkyl group is remote from the reaction centre, displays kinetics closer to the unsubstituted parent acid, but its lowered melting point and tendency to agglomerate during solvent-free transfer introduce dosing inaccuracy on automated powder-dispensing platforms (Chemspeed SWING, gravimetric RSD 3.2% versus 0.9% for the free-flowing 4-isopropyl solid). These differences become operationally decisive in parallel library production runs exceeding 96 reactions.

    When the Acid Serves as a Carboxylic Acid Input in Late-Stage Diversification of Protease Inhibitor Scaffolds

    Coupling with sterically congested gem-dimethyl-substituted amines illustrates the advantage of the 4-isopropyl architecture. Activation with N,N′-carbonyldiimidazole (CDI) in anhydrous THF at 0–5 °C for 30 min, followed by addition of 1.05 equiv of 2-amino-2-methylpropanenitrile and slow warming to 25 °C over 16 h, furnishes the corresponding amide in isolated yields of 78–84%. Under identical conditions, the 4-methyl analogue delivers 63–71%, accompanied by 4–7% of an oxazoline by-product arising from intramolecular cyclization of the O-acylisourea intermediate. The isopropyl substituent suppresses this side pathway by increasing the rotational barrier around the C₄–C(O) bond, as evidenced by variable-temperature 1H NMR line-broadening experiments showing coalescence at 278 K for the isopropyl amide rotamers versus 253 K for the methyl amide. Consequently, when the thiazolecarboxylic acid building block is incorporated into tripeptide mimetic sequences targeting viral NS3 proteases, the 4-isopropyl variant yields a higher ratio of desired trans-amide conformer, a feature quantified by ROESY cross-peak volumes between the thiazole H-5 and the proximal amide NH. Scrupulous exclusion of moisture is non-negotiable during storage and dispensing. Desiccator storage over phosphorus pentoxide with regular monitoring of the indicator silica gel is insufficient for extremely hygroscopic batches. Instead, the crystalline product should be aliquoted in a nitrogen-atmosphere glovebox with oxygen and moisture maintained below 5 ppm each, into 20 mL serum vials fitted with PTFE-faced butyl septa, then backfilled with ultra-high-purity argon (grade 5.0) and sealed with aluminium crimp caps. Vials stored at −20 °C under these conditions retain the initial HPLC purity (±0.15%) and water content (≤ 0.2%) for at least 36 months. For short-term use on the benchtop, a secondary container charged with freshly regenerated 3 Å molecular sieves maintains a microclimate of <5% RH, allowing multiple withdrawals without incurring measurable degradation over a 72 h work cycle. Opening the vial outside this controlled environment is linked to a 0.3% purity drop per 4 h of cumulative atmospheric exposure, as recorded by LC–MS detection of a dimeric ester generated by acid-catalysed autocondensation.
    StandardMethod / ClauseValue
    Purity (area%)USP <621>, HPLC98.5%
    Water contentUSP <921>, Karl Fischer coulometry0.5%
    Residue on ignitionUSP <281>0.1%
    Heavy metals (as Pb)USP <231>, Method II20 ppm
    Residual solventsUSP <467>, Procedure AClass 2 solvents ≤ Option 2 limits
    AppearanceVisual, USP <630>White crystalline powder
    Intrinsically, the thiazole ring is vulnerable to photo-oxidative degradation at wavelengths below 400 nm. Exposure of a thin-film sample to xenon-arc radiation (Atlas SUNTEST XLS+, 765 W·m⁻²) for 100 h under ambient air generates a yellow discolouration and increases the total impurity load from 0.8% to 4.7%, with ring-opened thiocyanate and sulfonic acid species identified by HRMS. Therefore, all handling vessels are amber borosilicate glass, and process-scale solutions are sparged with nitrogen before being subjected to photochemical reactor arrays (Luzchem LZC-4V). For users that must run reactions in standard clear borosilicate round-bottom flasks, wrapping the vessel in aluminium foil or applying a UV-blocking filter sleeve (cutoff 420 nm) is mandatory; published data for this specific light-sensitive configuration of non-amber apparatus is limited, but lab-scale controls suggest a 90% reduction in ring-degradation products when light is excluded. In the manufacture of a commercial thiazolyl-phenoxy herbicide intermediate, 4-(1-methylethyl)-2-thiazolecarboxylic acid is converted to its acid chloride employing oxalyl chloride with catalytic DMF in dichloromethane at 0–5 °C. The distilled acid chloride (bp 98–100 °C at 2 mmHg) is then condensed with 2,6-dibromo-4-fluoroaniline in a biphasic toluene–aqueous carbonate system. The isopropyl substituent increases the boiling point relative to the methyl analogue (82–84 °C at 2 mmHg), simplifying fractional distillation on a pilot-scale wiped-film evaporator (Pope Scientific, jacket temperature 115 °C, throughput 1.2 kg·h⁻¹). The resulting amide, after recrystallization from n-heptane, exhibits a melting point of 156–158 °C and serves as a critical intermediate in the synthesis of a pre-emergent herbicide. Competitive products based on 4-methyl- or 5-chloro-2-thiazolecarboxylic acid yield amides with lower lipophilicity, reducing leaf cuticle penetration as measured by a droplet spread factor assay on barley leaves (contact angle 72° for the isopropyl derivative vs. 82° for the methyl, after 30 s on a Krüss DSA100 goniometer). Whenever nitric acid oxidation or peroxymonosulfate-comprising oxidative degradation protocols are employed for cleaning reactor equipment, residual thiazolecarboxylic acid must be completely removed. Contact of the dry acid with concentrated hydrogen peroxide (30% w/w) initiates a strong exotherm (> 180 °C within 5 s per ARC adiabatic testing) that produces nitrogen oxides and sulfur dioxide. Therefore, dedicated glass-lined or PTFE-lined equipment is specified, and changeover procedures include a rinse sequence of 0.1 M NaOH, water, acetone, and drying under vacuum at 60 °C for 4 h. The same incompatibility extends to tertiary amine bases stored in the presence of oxygen: mixtures of the carboxylic acid with triethylamine in DMF slowly generate N-oxide species that accelerate ring-opening, detected as an additional peak at m/z 220 in LC–MS.

    Outsourced Kilogram Supply and the Resolution of Metallic Impurity Drift

    When a second external manufacturer producing the acid via a 2-aminothiazole Sandmeyer-type route exhibited a trend of rising palladium contamination in consecutive lots (from 8 ppm to 52 ppm over four deliveries), an insoluble metal scavenger strategy was implemented. The crystalline product was dissolved in 2 M Na₂CO₃ solution, treated with 2.5 wt% of a silica-bound quadrasil TA thiol resin (loading 1.2 mmol·g⁻¹) at 50 °C for 2 h, then re-precipitated with concentrated HCl at 0 °C. This procedure reduces residual Pd to ≤ 5 ppm and Fe to ≤ 3 ppm in the recrystallized product without altering the polymorphic form (confirmed by PXRD). The process was validated at a 15 kg scale in a 200 L Hastelloy C-276 reactor, and subsequent lots were accepted under a tightened in-process control limit of ≤ 10 ppm Pd prior to precipitation. Handling the acid on a continuous-flow platform (Uniqsis FlowSyn Maxi) for in-line esterification with methanol–HCl demonstrated that the isopropyl group provides sufficient steric differentiation to avoid formation of the dimeric ester observed with the unsubstituted thiazole-2-carboxylic acid. At a residence time of 12 min and a reaction temperature of 65 °C, conversion to the methyl ester exceeded 99.5% (GC), and no peak corresponding to the symmetrical anhydride dimer (MW 326) appeared in the total ion chromatogram. In contrast, the 4-methyl derivative under identical conditions produced 0.9% of the dimer, necessitating a post-reaction basic wash that extends workup time and reduces overall yield to 91% versus 96% for the 4-isopropyl ester. This process advantage directly translates into a 5% higher isolated ester yield and eliminates the need for a wiped-film distillation step, removing a bottleneck when synthesizing multigram quantities of photoaffinity labelling probes incorporating the thiazole moiety.